Abstract
Interleukin-6 (IL-6), an immune protein in the hematopoietins family, has been demonstrated as a prognostic indicator for survival in patients with gastric carcinoma. In this contribution, we introduced a new and high-throughput electrochemical immunosensor for the detection of IL-6 in human. The immunoassay protocol was fabricated by the immobilization of anti-IL-6 antibodies on the nanogold and partial ferrocenyltethered dendrimer (Fc-D)-functionalized interface. A sandwich-type immunoassay format was employed for the IL-6 determination using horseradish peroxidase (HRP)-labeled anti-IL-6 as secondary antibody. The properties and factors influencing the performance of the proposed immunosensor were evaluated in detail. Under optimal conditions, the current response of the formed sandwich-type immunocomplex relative to H2O2 system was proportional to IL-6 concentration ranging from 2.5 pg/mL to 120 pg/mL with a detection limit of 1.0 pg/mL (at 3δ). The precision, reproducibility and stability of the immunosensor were acceptable. Subsequently, the immunosensors were used to assay the IL-6 in human serum specimens. Analytical results were in agreement with those obtained by the standard chemiluminescence ELISA.
Keywords: Dendrimer, Electrochemical immunosensor, Gold nanoparticles, Interleukin-6, Sandwich-type enzyme immunoassay
Current Pharmaceutical Analysis
Title: High-Throughput Miniaturized Immunoassay for Human Interleukin-6 Using Electrochemical Sandwich-Type Enzyme Immunosensors
Volume: 5 Issue: 2
Author(s): Jiayao Liao and Dianping Tang
Affiliation:
Keywords: Dendrimer, Electrochemical immunosensor, Gold nanoparticles, Interleukin-6, Sandwich-type enzyme immunoassay
Abstract: Interleukin-6 (IL-6), an immune protein in the hematopoietins family, has been demonstrated as a prognostic indicator for survival in patients with gastric carcinoma. In this contribution, we introduced a new and high-throughput electrochemical immunosensor for the detection of IL-6 in human. The immunoassay protocol was fabricated by the immobilization of anti-IL-6 antibodies on the nanogold and partial ferrocenyltethered dendrimer (Fc-D)-functionalized interface. A sandwich-type immunoassay format was employed for the IL-6 determination using horseradish peroxidase (HRP)-labeled anti-IL-6 as secondary antibody. The properties and factors influencing the performance of the proposed immunosensor were evaluated in detail. Under optimal conditions, the current response of the formed sandwich-type immunocomplex relative to H2O2 system was proportional to IL-6 concentration ranging from 2.5 pg/mL to 120 pg/mL with a detection limit of 1.0 pg/mL (at 3δ). The precision, reproducibility and stability of the immunosensor were acceptable. Subsequently, the immunosensors were used to assay the IL-6 in human serum specimens. Analytical results were in agreement with those obtained by the standard chemiluminescence ELISA.
Export Options
About this article
Cite this article as:
Liao Jiayao and Tang Dianping, High-Throughput Miniaturized Immunoassay for Human Interleukin-6 Using Electrochemical Sandwich-Type Enzyme Immunosensors, Current Pharmaceutical Analysis 2009; 5 (2) . https://dx.doi.org/10.2174/157341209788172942
DOI https://dx.doi.org/10.2174/157341209788172942 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cytotoxic and Apoptogenic Activity of a Methanolic Extract from the Marine Invertebrate Ciona intestinalis on Malignant Cell Lines
Medicinal Chemistry Connecting Small Molecules to Nuclear Receptor Pathways
Current Topics in Medicinal Chemistry The Activating Receptors of Natural Killer Cells and Their Inter-Switching Potentials
Current Drug Targets Recent Applications of Artificial Intelligence in Early Cancer Detection
Current Medicinal Chemistry From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Review of the Biological Activity of Maslinic Acid
Current Drug Targets Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors
Current Enzyme Inhibition A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century
Current Medicinal Chemistry Artemia species: An Important Tool to Screen General Toxicity Samples
Current Pharmaceutical Design Antitumor Properties of Natural Compounds and Related Molecules
Recent Patents on Anti-Cancer Drug Discovery A Review of Natural and Modified Betulinic, Ursolic and Echinocystic Acid Derivatives as Potential Antitumor and Anti-HIV Agents
Mini-Reviews in Medicinal Chemistry p53-Induced Apoptosis and Inhibitors of p53
Current Medicinal Chemistry Clinical Practice of Umbilical Cord Blood Stem Cells in Transplantation and Regenerative Medicine - Prodigious Promise for Imminent Times
Recent Patents on Biotechnology Multi-Target Drugs for Neglected Diseases
Current Pharmaceutical Design SDH Genes: From Glomic Tumours to Pheochromocytomas
Current Hypertension Reviews Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma
Current Cancer Therapy Reviews Oncolytic Viruses for Induction of Anti-Tumor Immunity
Current Pharmaceutical Biotechnology Inhibiting the “Undruggable” RAS/Farnesyltransferase (FTase) Cancer Target by Manumycin-related Natural Products
Current Medicinal Chemistry Molecular and Biological Aspects of the Bovine Immunodeficiency Virus
Current HIV Research Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling
Current Cancer Drug Targets